{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:16:43Z","timestamp":1791127003601,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012127","name":"Augusta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012127","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ygyno.2024.07.685","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:35:29Z","timestamp":1723044929000},"page":"129-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes"],"prefix":"10.1016","volume":"189","author":[{"given":"Jennifer","family":"Vaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Piver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogna","family":"Brzezinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessa","family":"Suhner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Sareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Vuppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlo","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunja","family":"Rungruang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Ghamande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"McIndoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mysona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.07.685_bb0005","first-page":"48","article-title":"Immunotherapy in gynecological cancers","volume":"2","author":"Lorusso","year":"2021","journal-title":"Explor. Target Antitumor. Ther."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0010","first-page":"747","article-title":"Immunotherapy through the years","volume":"8","author":"Eno","year":"2017","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0015","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical Cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0020","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial Cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0025","series-title":"Immunotherapy in Gynecologic Cancers: What we Know Now and where we Are Headed","first-page":"e126","author":"Levinson","year":"2019"},{"key":"10.1016\/j.ygyno.2024.07.685_bb0030","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2022.33.e77","article-title":"Immunonutrition in ovarian cancer: clinical and immunological impact?","volume":"33","author":"Ferrero","year":"2022","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.823087","article-title":"Prognostic nutritional index predicts response and prognosis in Cancer patients treated with immune checkpoint inhibitors: a systematic review and Meta-analysis","volume":"9","author":"Ni","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0040","first-page":"13","article-title":"Nutritional status as a predictive biomarker for immunotherapy outcomes in advanced head and neck Cancer","author":"Guller","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2024.07.685_bb0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2017.01.028","article-title":"Nutrition interventions in patients with gynecological cancers requiring surgery","volume":"145","author":"Obermair","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0050","first-page":"4","article-title":"Nutrition in gynecologic Cancer","author":"Cantrell","year":"2015","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0055","first-page":"1001","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0060","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.21037\/atm-21-4528","article-title":"Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review","volume":"9","author":"Yan","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0065","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/01635581.2017.1367947","article-title":"Clinical value of nutritional status in Cancer: what is its impact and how it affects disease progression and prognosis?","volume":"69","author":"Mantzorou","year":"2017","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ygyno.2024.07.685_bb0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2024.07.685_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021840","article-title":"Prognostic significance of preoperative prognostic nutritional index in ovarian cancer: a systematic review and meta-analysis","volume":"99","author":"Dai","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ygyno.2024.07.685_bb0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2022.05.012","article-title":"The five-factor modified frailty index predicts adverse postoperative and chemotherapy outcomes in gynecologic oncology","volume":"166","author":"Mah","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0085","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1200\/JCO.23.00914","article-title":"First-line Pembrolizumab + chemotherapy versus placebo + chemotherapy for persistent, recurrent, or metastatic cervical Cancer: final overall survival results of KEYNOTE-826","volume":"41","author":"Monk","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.23.02132","article-title":"Durvalumab plus carboplatin\/paclitaxel followed by maintenance Durvalumab with or without Olaparib as first-line treatment for advanced endometrial Cancer: the phase III DUO-E trial","volume":"42","author":"Westin","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.07.685_bb0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","article-title":"High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types","volume":"32","author":"McGrail","year":"2021","journal-title":"Ann. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824010497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T17:23:32Z","timestamp":1726248212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824010497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":19,"alternative-id":["S0090825824010497"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.07.685","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.07.685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}